What clinically isolated syndrome is
Multiple sclerosis is diagnosed by showing that demyelination has happened in more than one place in the central nervous system and, in most cases, at more than one time. A first episode, by definition, can only show one time. Clinically isolated syndrome, or CIS, is the name for that first episode when it has the character of MS but the evidence does not yet add up to the diagnosis. It is a description of where you are in the process, not a separate disease.
The label is honest rather than evasive. Some people who have a single episode never have another, and their scans stay clean. Others are in the first chapter of relapsing-remitting MS. The work of the first visit is to tell those two groups apart as accurately as the evidence allows, and to set out a plan for whichever one you are in.
Visual guide
Where a first episode happens
- Optic nerve: Dim or blurred vision in one eye with pain on eye movement.
- Spinal cord: Numbness, weakness, or a band of tightness, often on one side or below one level.
- Brainstem: Double vision, vertigo, facial numbness, or unsteadiness.
Symptoms
A CIS episode has a shape. It comes on over hours to days, plateaus, lasts weeks, and then improves, often almost completely. There is no fever or infection to explain it. The three classic presentations:
- Optic neuritis. Vision in one eye becomes dim, blurred, or washed out over a few days, with an ache behind the eye that is worse on movement. Colors look faded. Most people recover most of their vision over weeks to months.
- Partial transverse myelitis. Numbness, tingling, or weakness that rises over days, often on one side of the body or below a level on the trunk, sometimes with a tight band sensation, bladder urgency, or Lhermitte's sign. Our guide to transverse myelitis and MS covers this form in depth.
- Brainstem or cerebellar syndrome. Double vision, vertigo, facial numbness, slurred speech, or clumsiness and unsteadiness.
A CIS can also involve more than one of these areas at once, which points more strongly toward MS.
What are the chances it becomes MS?
The MRI at the time of the first episode is the strongest predictor we have. In the long-term studies, people whose first scan showed MS-typical white matter lesions had a high chance of a second attack or new lesions within a few years, and most had a diagnosis of MS within a decade. People whose first scan was clean had a low chance, on the order of one in five over the same period. The number of lesions, their location, and whether the spinal fluid shows oligoclonal bands or kappa free light chains refine that estimate further.
The 2024 McDonald criteria changed what happens with that information. When a first episode comes with lesions in enough of the typical locations, or with specific spinal fluid or advanced MRI markers, MS can now be diagnosed at that first visit rather than waiting for a second event. The practical effect is that fewer people are left with the CIS label, and those who are have genuinely uncertain findings and a clear monitoring plan.
How CIS is evaluated
The MS evaluation after a first episode has two jobs. The first is to make sure the episode was demyelination and not one of the conditions that mimic MS: a stroke, a compressed nerve or spinal cord, a vitamin B12 deficiency, an infection, or an inflammatory disease elsewhere in the body. The second is to look for the other demyelinating diseases that present the same way and are treated differently. Optic neuritis and myelitis are also the classic first attacks of NMOSD and MOG antibody disease, so antibody blood tests for aquaporin-4 and MOG are part of the workup when the picture fits.
The core tests are MRI of the brain and full spinal cord with contrast, blood tests, and often a lumbar puncture. Optic neuritis may add an eye examination and optical coherence tomography, a painless scan of the retina.
Treatment and what happens next
The episode itself is usually treated with a short course of high-dose steroids when it is disabling, which speeds recovery. The longer question is whether to start a disease-modifying therapy. For people whose MRI shows MS-typical lesions, the trials are consistent: starting treatment after a first episode delays the second and reduces new lesions, and the benefit persists years later. For people with a clean scan, the risk is low enough that watching with a repeat MRI is reasonable. In between, the decision is made together, weighing the lesion burden, the spinal fluid, your age, plans for family, and your own view of risk. Our treatment guide explains the options.
Whatever is decided, the plan should be specific: when the next MRI is due, what change would confirm MS or prompt treatment, and what to do if a new symptom appears in the meantime.
Visual guide
After a first episode
- Repeat MRI: Scheduled months apart to look for new lesions, with or without symptoms.
- Decision point: New lesions or a second episode usually confirm MS and change treatment.
- Between scans: A new symptom lasting more than 24 hours is a reason to call, not wait.
When to see a neurologist
See a neurologist promptly, within days rather than weeks, for a first episode of vision loss in one eye with pain, numbness or weakness that builds over days, or double vision or vertigo that does not settle. Once the episode has been evaluated, an MS specialist is the right person to interpret the MRI and decide with you whether to treat. At our Multiple Sclerosis Clinic, Dr. Ntranos, a fellowship-trained MS specialist, reviews your images directly and sees new patients usually the same or next day, in Beverly Hills, West Los Angeles, or by video anywhere in California.
Frequently asked questions
References
- Miller DH, et al. Clinically isolated syndromes. The Lancet Neurology, 2012.
- Kappos L, et al. The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology, 2016.
- Montalban X, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. The Lancet Neurology, 2025.
- National Institute of Neurological Disorders and Stroke. Multiple sclerosis.
- National Multiple Sclerosis Society. Types of MS.